NewsBenzingaSeaStar Medical informa una tasa de supervivencia del 65,1 % al día 90 en su análisis del registro SAVE de QUELIMMUNE presentado en la Semana del Riñón de la ASN 2026 SeaStar Medical informa una tasa de supervivencia del 65,1 % al día 90 en su análisis del registro SAVE de QUELIMMUNE presentado en la Semana del Riñón de la ASN 2026 Benzinga 2026.10.22 16:05 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Fifth Third Bancorp, Raises Price Target to $63 Citigroup Maintains Buy on East West Bancorp, Raises Price Target to $155 Citigroup Maintains Neutral on BOK Financial, Lowers Price Target to $140 Citigroup Maintains Buy on Westinghouse Air Brake, Lowers Price Target to $334 Citigroup Maintains Neutral on Integra Lifesciences, Lowers Price Target to $14 Citigroup Maintains Buy on Pegasystems, Lowers Price Target to $50
